Genmab A/S's total assets for Q4 2023 were $35.29B, an increase of 17.17% from the previous quarter. GB:0MGB total liabilities were $3.68B for the fiscal quarter, a 29.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.